Rayzebio Inc (RYZB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RYZB | AMGN | VRTX | REGN | GILD |
| Company | Rayzebio Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 62.49 | 311.49 | 477.52 | 1,042.28 | 68.24 |
| High | 62.50 | 312.54 | 477.52 | 1,047.25 | 68.33 |
| Low | 62.48 | 306.11 | 466.01 | 1,011.67 | 66.66 |
| Last | 62.49 | 306.79 | 468.41 | 1,022.08 | 67.14 |
| Change | +0.01 | -3.98 | -5.37 | -22.58 | -1.26 |
| % Change | +0.02% | -1.28% | -1.13% | -2.16% | -1.84% |
| Volume | 282,700 | 292,118 | 287,459 | 120,798 | 1,287,745 |
| 20-Day Average Volume | 318,060 | 2,350,560 | 1,240,417 | 463,801 | 9,054,817 |
| Previous Close | 62.48 | 310.77 | 473.78 | 1,044.66 | 68.40 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 62.28 | 307.77 | 475.46 | 1,035.90 | 66.65 |
| 20-Day Raw Stochastic | 95.83% | 41.69% | 16.47% | 28.24% | 42.02% |
| 20-Day Relative Strength | 86.10% | 53.32% | 55.49% | 51.18% | 48.92% |
| Weighted Alpha | N/A | +34.76 | +38.94 | +41.66 | -13.55 |
| Today's Opinion | N/A | 100% Buy | 88% Buy | 80% Buy | 40% Sell |
| Previous Opinion | N/A | 100% Buy | 88% Buy | 100% Buy | 40% Sell |
| Last Month's Opinion | N/A | 72% Buy | 88% Buy | 88% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.13% since 02/15/24 | -1.49% since 06/26/24 | -1.47% since 06/26/24 | -5.01% since 06/26/24 | -3.80% since 06/26/24 |
| Low | 62.42 on 02/16/24 | 307.64 on 07/02/24 | 466.01 on 07/03/24 | 1,014.37 on 07/03/24 | 66.66 on 07/03/24 |
| High | 62.51 on 02/22/24 | 319.00 on 07/01/24 | 478.96 on 07/01/24 | 1,073.05 on 06/27/24 | 69.99 on 07/01/24 |
| 1-Month | |||||
| %Chg | +0.87% since 01/23/24 | +0.24% since 06/03/24 | -0.67% since 06/03/24 | +2.64% since 06/03/24 | +5.12% since 06/03/24 |
| Low | 61.86 on 01/24/24 | 295.30 on 06/13/24 | 463.23 on 06/20/24 | 986.64 on 06/04/24 | 62.69 on 06/18/24 |
| High | 62.51 on 02/22/24 | 326.12 on 06/25/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 72.18 on 06/21/24 |
| 3-Month | |||||
| %Chg | +167.05% since 11/22/23 | +12.29% since 04/03/24 | +14.25% since 04/03/24 | +6.80% since 04/03/24 | -5.95% since 04/03/24 |
| Low | 22.14 on 11/27/23 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 62.51 on 02/22/24 | 326.12 on 06/25/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 72.18 on 06/21/24 |
| 6-Month | |||||
| %Chg | N/A since 09/15/23 | +2.48% since 01/03/24 | +13.72% since 01/03/24 | +10.68% since 01/03/24 | -20.13% since 01/03/24 |
| Low | 17.95 on 09/26/23 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 62.51 on 02/22/24 | 329.72 on 02/05/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,744,400 | 166,707,904 | 122,260,352 | 115,106,896 | 85,216,352 |
| Shares Outstanding, K | 59,920 | 536,435 | 258,053 | 110,186 | 1,245,853 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -68,600,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 6,686,000,000 |
| Last Quarter Net Income | -18,190,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -4,170,000,000 |
| 60-Month Beta | N/A | 0.58 | 0.39 | 0.13 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.26 on 11/13/23 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 03/04/24 | 08/01/24 | 08/06/24 | 08/01/24 | 08/01/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.770 on 06/14/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.69 | 31.29 | 28.48 | 17.03 |